Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
J Clin Immunol
.
2021 Jul;41(5):926-929.
doi: 10.1007/s10875-021-00996-7.
Epub 2021 Feb 20.
Authors
Emily McKemey
#
1
,
Adrian M Shields
#
2
3
,
Sian E Faustini
4
,
Harriet J Hill
5
,
Aliaksandra Barnskaya
1
,
Zania Stamataki
5
,
Simon Gompertz
1
,
Alex G Richter
1
4
,
Davinder Dosanjh
1
,
Shyam Madathil
1
Affiliations
1
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
2
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. a.m.shields@bham.ac.uk.
3
Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. a.m.shields@bham.ac.uk.
4
Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
5
Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
#
Contributed equally.
PMID:
33611660
PMCID:
PMC7896874
DOI:
10.1007/s10875-021-00996-7
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
B-Lymphocytes
COVID-19 Serotherapy
COVID-19* / therapy
Coronavirus Infections*
Humans
Immunization, Passive
SARS-CoV-2
Grants and funding
MRF_MRF-169-0001-F-STAM-C0826/MRF/MRF/United Kingdom
The Institute for Global Innovation/University of Birmingham
Global Challenges Research Fund/University of Birmingham
MC_PC_17183/MRC_/Medical Research Council/United Kingdom